Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Even if Swartz would own their maximum of 25mio shares, this would "only" equal to about 6,1% ownership.
Thus again my question:
Why is Turley speaking of 8% maximum ownership?

For me there are only two possibilities:
1. Swartz bought additional shares before the warrant-buyback-agreement (which I doubt)
2. Someone else bought shares (but then we should see a filing)

Hm...

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply